APX-OLMESARTAN/HCTZ 40/12.5 olmesartan medoxomil and hydrochlorothiazide 40/12.5 mg tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apx-olmesartan/hctz 40/12.5 olmesartan medoxomil and hydrochlorothiazide 40/12.5 mg tablet blister pack

pharmacor pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet - excipient ingredients: hyprolose; lactose monohydrate; magnesium stearate; microcrystalline cellulose; purified water; stearic acid; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000; iron oxide red; macrogol 400 - olmesartan medoxomil and hydrochlorothiazide is indicated for:,treatment of hypertension.,treatment should not be initiated with this fixed dose combination.

APX-OLMESARTAN/HCTZ 40/25 olmesartan medoxomil and hydrochlorothiazide 40/25 mg tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apx-olmesartan/hctz 40/25 olmesartan medoxomil and hydrochlorothiazide 40/25 mg tablet blister pack

pharmacor pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 25 mg - tablet - excipient ingredients: magnesium stearate; stearic acid; microcrystalline cellulose; lactose monohydrate; hyprolose; purified water; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000; iron oxide red; macrogol 400 - olmesartan medoxomil and hydrochlorothiazide is indicated for:,treatment of hypertension.,treatment should not be initiated with this fixed dose combination.

AKM-OLMESARTAN HCTZ 40/12.5 olmesartan medoxomil and hydrochlorothiazide 40/12.5 mg tablet bottle pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

akm-olmesartan hctz 40/12.5 olmesartan medoxomil and hydrochlorothiazide 40/12.5 mg tablet bottle pack

pharmacor pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet - excipient ingredients: hyprolose; magnesium stearate; purified water; stearic acid; lactose monohydrate; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000; iron oxide red; macrogol 400 - olmesartan medoxomil and hydrochlorothiazide is indicated for:,treatment of hypertension.,treatment should not be initiated with this fixed dose combination.

OLMESARTAN/ AMLODIPINE Australia - engelsk - Department of Health (Therapeutic Goods Administration)

olmesartan/ amlodipine

organon pharma pty ltd - amlodipine besilate, quantity: 6.944 mg (equivalent: amlodipine, qty 5 mg); olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; croscarmellose sodium; pregelatinised maize starch; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - olmesartan/ amlodipine-myl is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

APO-OLMESARTAN/AMLODIPINE/HCTZ 40/5/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/5/12.5 mg film-coated tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apo-olmesartan/amlodipine/hctz 40/5/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/5/12.5 mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 6.95 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: isopropyl alcohol; pregelatinised maize starch; magnesium stearate; povidone; lactose monohydrate; silicified microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - apo-olmesartan/amlodipine/hctz 40/5/12.5 mg is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination. this fixed dose combination is not indicated for initial therapy.

Olmesartan/Vocate 10mg film-coated Tablets Malta - engelsk - Medicines Authority

olmesartan/vocate 10mg film-coated tablets

vocate pharmaceuticals s.a 150, gounari str, 166 74 glyfada, athens, greece - olmesartan medoxomil - film-coated tablet - olmesartan medoxomil 10 mg - agents acting on the renin-angiotensin system

Olmesartan/Vocate 20mg film-coated Tablets Malta - engelsk - Medicines Authority

olmesartan/vocate 20mg film-coated tablets

vocate pharmaceuticals s.a 150, gounari str, 166 74 glyfada, athens, greece - olmesartan medoxomil - film-coated tablet - olmesartan medoxomil 20 mg - agents acting on the renin-angiotensin system

Olmesartan/Vocate 40mg film-coated Tablets Malta - engelsk - Medicines Authority

olmesartan/vocate 40mg film-coated tablets

vocate pharmaceuticals s.a 150, gounari str, 166 74 glyfada, athens, greece - olmesartan medoxomil - film-coated tablet - olmesartan medoxomil 40 mg - agents acting on the renin-angiotensin system

OLMESARTAN MEDOXOMIL TEVA Irland - engelsk - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil teva

teva pharma b.v. - olmesartan medoxomil - film coated tablet - 10 milligram - olmesartan medoxomil

OLMESARTAN MEDOXOMIL TEVA Irland - engelsk - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil teva

teva pharma b.v. - olmesartan medoxomil - film coated tablet - 40 milligram - olmesartan medoxomil